![Cameron Carvalho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cameron Carvalho held positions as Vice President of Business Development at Purdue Pharma (Canada) and Cybin, Inc., as well as an Associate role at Canada Pension Plan Investment Board Private Investments.
| Companies | Position | End |
|---|---|---|
| CYBIN INC. | Corporate Officer/Principal | - |
Purdue Pharma (Canada)
 Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Canada Pension Plan Investment Board Private Investments
 Canada Pension Plan Investment Board Private Investments Investment ManagersFinance CPPIB Private Investments invests in companies located across the globe primarily in North America, Europe and Asia. The firm targets companies operating in the fields of technology, healthcare, industrials and service sectors. It provides financing for buyout, secondary and growth stage capital requirements with an investment size of USD 25 - 300 million. It acquires minority interest and also makes co-investments. | Private Equity Analyst | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Purdue Pharma (Canada)
Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Canada Pension Plan Investment Board Private Investments
Canada Pension Plan Investment Board Private Investments Investment ManagersFinance CPPIB Private Investments invests in companies located across the globe primarily in North America, Europe and Asia. The firm targets companies operating in the fields of technology, healthcare, industrials and service sectors. It provides financing for buyout, secondary and growth stage capital requirements with an investment size of USD 25 - 300 million. It acquires minority interest and also makes co-investments. | Finance |
Cybin, Inc.
 Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
